Mechanisms Involved in the Benefits of an Exercise Programme in Patients With Cirrhosis
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The investigators conducted a pilot study including 17 patients with liver cirrhosis showing that a moderate exercise programme during three months increased thigh circumference,exercise tolerance and quality of life without adverse effects. The present study aim to more accurately evaluate the effect of exercise on muscle mass, effort tolerance and inflammatory response in patients with cirrhosis. This study will include 30 patients with compensated liver cirrhosis that will be randomized into two groups: exercise group and control group. Evaluation of muscle mass, effort tolerance, inflammatory response and quality of life will be made at the beginning and at the end of the study.
| Condition | Intervention |
|---|---|
|
Cirrhosis |
Other: Exercise + relaxation Other: Relaxation |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Prevention |
- Increase in muscle mass [ Time Frame: Basal and three months ] [ Designated as safety issue: Yes ]
- Change in Effort tolerance [ Time Frame: Basal and three months ] [ Designated as safety issue: Yes ]
| Estimated Enrollment: | 30 |
| Study Start Date: | October 2011 |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: Exercise, relaxation
Active comparator: Exercise + relaxation Patients will perform exercise + relaxation for 3 months
|
Other: Exercise + relaxation
Exercise + relaxation
|
|
Relaxation
Relaxation without exercise Patients will receive only relaxation for 3 months
|
Other: Relaxation
Relaxation without exercise Patients will receive only relaxation for 3 months
|
Detailed Description:
Exercise group: will do a physiotherapist supervised exercise programme 1 hour three times per week during three months and relaxation after exercise. Control group: only relaxation 1 hour three times per week during three months.
Assessment: clinical and laboratory examinations performed at baseline and at the end of the study. The investigators will analyze the changes in muscle mass by anthropometric measurements and advanced techniques (CT scan, densitometry), effort tolerance (stress test), quality of life (sF-36), glutamine synthetase activity in blood, oxidative damage and inflammatory response. The investigators will analyze the survival and complications of cirrhosis during the study and follow-up.
Eligibility| Ages Eligible for Study: | 18 Years to 80 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Compensated liver cirrhosis
Exclusion Criteria:
- hepatocellular carcinoma
- active alcoholism (less than 1 year)
- decompensated cirrhosis
- variceal bleeding less than 3 months.
- contraindication for exercise
Contacts and Locations| Contact: German Soriano MD PhD | +34935565920 | gsoriano@santpau.cat |
| Spain | |
| Hospital de la Santa Creu i Sant Pau | Recruiting |
| Barcelona, Spain, 08025 | |
| Contact: German Soriano MD PhD +34935565920 gsoriano@santpau.cat | |
| Principal Investigator: | German Soriano MD PhD | Department of Gastroenterology, Hospital de la Santa Creu i Sant Pau |
More Information
No publications provided
| Responsible Party: | German Soriano, Dr. German Soriano Pastor Principal Investigator, Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau |
| ClinicalTrials.gov Identifier: | NCT01447537 History of Changes |
| Other Study ID Numbers: | IIBSP-PEF-2010-50 |
| Study First Received: | September 28, 2011 |
| Last Updated: | October 5, 2011 |
| Health Authority: | Spain: Ministry of Health |
Keywords provided by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau:
|
Cirrhosis Exercise Relaxation Muscle mass Effort tolerance |
Additional relevant MeSH terms:
|
Liver Cirrhosis Fibrosis Liver Diseases Digestive System Diseases Pathologic Processes |
ClinicalTrials.gov processed this record on May 16, 2013